<p>联合健康集团（NYSE:UNH - 获取免费报告）的股票在周四由罗伯特·W·贝尔德在给投资者发布的报告中重申了 “表现不佳” 的评级，Marketbeat.com 报道。他们目前对该医疗保健集团的股票设定了 198.00 美元的目标价，低于之前的 312.00 美元目标价。罗伯特·W·贝尔德的目标价暗示该股票相较于之前收盘价有 23.54% 的潜在下跌空间。</p>
<p>获取 <strong>联合健康集团</strong> 的提醒：</p>
<ul>
<li>HCA 医疗保健能否复兴市场最弱的行业？</li>
</ul>
<p>其他一些研究分析师最近也对该股票发布了报告。瑞银集团在 7 月 17 日的研究报告中重申了对联合健康集团股票的 “买入” 评级。巴克莱在 7 月 17 日的研究报告中重申了对联合健康集团股票的 “增持” 评级。TD Cowen 将联合健康集团的股票评级从 “买入” 下调至 “持有”，并设定了 308.00 美元的目标价，报告日期为 5 月 19 日。汇丰全球研究在 5 月 21 日的研究报告中将联合健康集团的股票评级从 “持有” 下调至 “适度卖出”。最后，汇丰在 5 月 21 日的研究报告中重申了 “减持” 评级，并对联合健康集团的股票设定了 270.00 美元的目标价（低于 490.00 美元）。两位分析师对该股票给予了卖出评级，八位分析师给予了持有评级，十五位分析师给予了买入评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 373.52 美元。</p>
<p><strong>查看我们关于联合健康集团的最新股票报告</strong></p>
<h2>联合健康集团股票表现</h2>
<ul>
<li>医疗保健股票估值触底，3 只股票有望反弹</li>
</ul>
<p>NYSE:UNH 周四开盘价为 258.95 美元。联合健康集团的 52 周低点为 248.88 美元，52 周高点为 630.73 美元。该公司的市值为 2349 亿美元，市盈率为 11.54，PEG 比率为 1.37，贝塔值为 0.45。该公司的 50 日移动平均线为 298.96 美元，200 日移动平均线为 420.36 美元。公司的债务与股本比率为 0.73，速动比率为 0.85，流动比率为 0.85。</p>
<p>联合健康集团（NYSE:UNH - 获取免费报告）最近于 7 月 29 日发布了其财报。该医疗保健集团报告本季度每股收益为 4.08 美元，低于分析师一致预期的 4.45 美元，差额为 0.37 美元。该公司本季度的收入为 1116.2 亿美元，而一致预期为 1117.5 亿美元。联合健康集团的净利润率为 5.04%，股本回报率为 23.32%。该公司本季度的收入同比增长 12.9%。去年同期，该公司的每股收益为 6.80 美元。股票研究分析师预计联合健康集团今年的每股收益将达到 29.54 美元。</p>
<h2>联合健康集团的内部买卖</h2>
<ul>
<li>内部人士在过去两个月对这 3 只股票投入了数百万美元</li>
</ul>
<p>在相关消息中，首席财务官约翰·F·雷克斯在 5 月 16 日的交易中购买了 17,175 股该股票。每股的平均购买价格为 291.12 美元，总价值为 4,999,986.00 美元。完成购买后，首席财务官持有 203,796 股公司的股票，价值约为 59,329,091.52 美元。这代表其持股增加了 9.20%。该收购在向证券交易委员会提交的文件中披露，文件可在 SEC 网站上找到。此外，首席执行官斯蒂芬·J·赫姆斯利在 5 月 16 日的交易中购买了 86,700 股公司的股票。每股的平均购买价格为 288.57 美元，总交易额为 25,019,019.00 美元。收购完成后，首席执行官持有 679,493 股公司的股票，价值为 196,081,295.01 美元。这笔交易代表其持股增加了 14.63%。该购买的披露信息可以在这里找到。内部人士在上个季度共购买了 109,408 股公司股票，价值为 31,607,768 美元。内部人士持有公司股票的比例为 0.28%。</p>
<h2>对联合健康集团的对冲基金看法</h2>
<p>一些机构投资者最近对该股票的持仓进行了调整。GAMMA Investing LLC 在第一季度将其在联合健康集团的持仓增加了 56,142.1%。GAMMA Investing LLC 目前拥有 8,295,153 股该医疗保健集团的股票，价值为 43,445,860,000 美元，此前在上个季度购买了 8,280,404 股。Nuveen LLC 在第一季度获得了联合健康集团的新股份，价值约为 3,846,764,000 美元。先锋集团在第一季度将其在联合健康集团的股份增加了 6.6%。先锋集团目前拥有 90,729,585 股该医疗保健集团的股票，价值为 47,519,620,000 美元，此前在该期间购买了 5,583,343 股。威灵顿管理集团在第一季度将其在联合健康集团的股份增加了 10.6%。威灵顿管理集团目前拥有 25,847,940 股该医疗保健集团的股票，价值为 13,537,859,000 美元，此前在上个季度购买了 2,486,839 股。最后，瑞银资产管理美洲有限公司的一个独立业务单位在第四季度将其在联合健康集团的股份增加了 36.6%。瑞银资产管理美洲有限公司的这个独立业务单位目前拥有 8,592,718 股该医疗保健集团的股票，价值为 4,346,712,000 美元，此前在上个季度购买了 2,301,010 股。87.86% 的股票由机构投资者和对冲基金持有。</p>
<h2>关于联合健康集团</h2>
<p>（获取免费报告）</p>
<p>联合健康集团在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：UnitedHealthcare、Optum Health、Optum Insight 和 Optum Rx。UnitedHealthcare 部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务，以满足他们的需求；医疗补助计划、儿童健康保险和医疗保健项目；以及健康和牙科福利、医院和临床服务，以及为照顾经济困难、医疗服务不足和没有雇主资助医疗保险的州项目提供的医疗保健福利产品和服务。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们认为比联合健康集团更好的股票</li>
<li>交通运输股票投资</li>
<li>消费者信心上升可能使这三只零售股票受益</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>两家网络安全巨头即将迎来重大潜在突破</li>
<li>为什么这些公司被认为是蓝筹股？</li>
<li>Spotify 第二季度收益暴跌：机会还是不祥信号？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在联合健康集团吗？</h2>
<p>在考虑联合健康集团之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前立即购买……而联合健康集团并不在名单上。</p>
<p>虽然联合健康集团目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

联合健康

<p>罗伯特·W·贝尔德（Robert W. Baird）重申了对联合健康（UnitedHealth Group，UNH）的 “表现不佳” 评级，目标价为 198 美元，较之前的 312 美元下调。这意味着该股票的潜在下行空间为 23.54%。其他分析师的评级则各不相同，其中两家为卖出，八家为持有，十五家为买入。该股票开盘价为 258.95 美元，52 周区间为 248.88 美元至 630.73 美元。联合健康报告的每股收益为 4.08 美元，未达到预期，营收为 1116.2 亿美元，同比增长 12.9%。内部人士最近购买了股票，显示出对公司的信心</p>

<p>UnitedHealth Group (NYSE:UNH - Get Free Report)'s stock had its &#34;underperform&#34; rating reiterated by Robert W. Baird in a note issued to investors on Thursday, Marketbeat.com reports. They presently have a $198.00 price objective on the healthcare conglomerate's stock, down from their prior price objective of $312.00. Robert W. Baird's target price suggests a potential downside of 23.54% from the stock's previous close.</p>
<div class="lb-trans"><p>联合健康集团（NYSE:UNH - 获取免费报告）的股票在周四由罗伯特·W·贝尔德在给投资者发布的报告中重申了 “表现不佳” 的评级，Marketbeat.com 报道。他们目前对该医疗保健集团的股票设定了 198.00 美元的目标价，低于之前的 312.00 美元目标价。罗伯特·W·贝尔德的目标价暗示该股票相较于之前收盘价有 23.54% 的潜在下跌空间。</p>
</div><p>Get <strong>UnitedHealth Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>联合健康集团</strong> 的提醒：</p>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA 医疗保健能否复兴市场最弱的行业？</li>
</ul>
</div><p>A number of other research analysts have also recently issued reports on the stock. UBS Group reissued a &#34;buy&#34; rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Barclays reiterated an &#34;overweight&#34; rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. TD Cowen downgraded shares of UnitedHealth Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. Hsbc Global Res downgraded shares of UnitedHealth Group from a &#34;hold&#34; rating to a &#34;moderate sell&#34; rating in a research report on Wednesday, May 21st. Finally, HSBC reiterated a &#34;reduce&#34; rating and issued a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $373.52.</p>
<div class="lb-trans"><p>其他一些研究分析师最近也对该股票发布了报告。瑞银集团在 7 月 17 日的研究报告中重申了对联合健康集团股票的 “买入” 评级。巴克莱在 7 月 17 日的研究报告中重申了对联合健康集团股票的 “增持” 评级。TD Cowen 将联合健康集团的股票评级从 “买入” 下调至 “持有”，并设定了 308.00 美元的目标价，报告日期为 5 月 19 日。汇丰全球研究在 5 月 21 日的研究报告中将联合健康集团的股票评级从 “持有” 下调至 “适度卖出”。最后，汇丰在 5 月 21 日的研究报告中重申了 “减持” 评级，并对联合健康集团的股票设定了 270.00 美元的目标价（低于 490.00 美元）。两位分析师对该股票给予了卖出评级，八位分析师给予了持有评级，十五位分析师给予了买入评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 373.52 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on UnitedHealth Group</strong></p>
<div class="lb-trans"><p><strong>查看我们关于联合健康集团的最新股票报告</strong></p>
</div><h2>UnitedHealth Group Stock Performance</h2>
<div class="lb-trans"><h2>联合健康集团股票表现</h2>
</div><ul>
<li>Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗保健股票估值触底，3 只股票有望反弹</li>
</ul>
</div><p>NYSE:UNH opened at $258.95 on Thursday. UnitedHealth Group has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a market cap of $234.90 billion, a price-to-earnings ratio of 11.54, a PEG ratio of 1.37 and a beta of 0.45. The firm's 50-day moving average is $298.96 and its 200-day moving average is $420.36. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.</p>
<div class="lb-trans"><p>NYSE:UNH 周四开盘价为 258.95 美元。联合健康集团的 52 周低点为 248.88 美元，52 周高点为 630.73 美元。该公司的市值为 2349 亿美元，市盈率为 11.54，PEG 比率为 1.37，贝塔值为 0.45。该公司的 50 日移动平均线为 298.96 美元，200 日移动平均线为 420.36 美元。公司的债务与股本比率为 0.73，速动比率为 0.85，流动比率为 0.85。</p>
</div><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period last year, the business posted $6.80 EPS. Equities research analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current year.</p>
<div class="lb-trans"><p>联合健康集团（NYSE:UNH - 获取免费报告）最近于 7 月 29 日发布了其财报。该医疗保健集团报告本季度每股收益为 4.08 美元，低于分析师一致预期的 4.45 美元，差额为 0.37 美元。该公司本季度的收入为 1116.2 亿美元，而一致预期为 1117.5 亿美元。联合健康集团的净利润率为 5.04%，股本回报率为 23.32%。该公司本季度的收入同比增长 12.9%。去年同期，该公司的每股收益为 6.80 美元。股票研究分析师预计联合健康集团今年的每股收益将达到 29.54 美元。</p>
</div><h2>Insider Buying and Selling at UnitedHealth Group</h2>
<div class="lb-trans"><h2>联合健康集团的内部买卖</h2>
</div><ul>
<li>Insiders Spent Millions on These 3 Stocks Over the Past 2 Months</li>
</ul>
<div class="lb-trans"><ul>
<li>内部人士在过去两个月对这 3 只股票投入了数百万美元</li>
</ul>
</div><p>In related news, CFO John F. Rex acquired 17,175 shares of the stock in a transaction on Friday, May 16th. The shares were bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The acquisition was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the business's stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 over the last quarter. Insiders own 0.28% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，首席财务官约翰·F·雷克斯在 5 月 16 日的交易中购买了 17,175 股该股票。每股的平均购买价格为 291.12 美元，总价值为 4,999,986.00 美元。完成购买后，首席财务官持有 203,796 股公司的股票，价值约为 59,329,091.52 美元。这代表其持股增加了 9.20%。该收购在向证券交易委员会提交的文件中披露，文件可在 SEC 网站上找到。此外，首席执行官斯蒂芬·J·赫姆斯利在 5 月 16 日的交易中购买了 86,700 股公司的股票。每股的平均购买价格为 288.57 美元，总交易额为 25,019,019.00 美元。收购完成后，首席执行官持有 679,493 股公司的股票，价值为 196,081,295.01 美元。这笔交易代表其持股增加了 14.63%。该购买的披露信息可以在这里找到。内部人士在上个季度共购买了 109,408 股公司股票，价值为 31,607,768 美元。内部人士持有公司股票的比例为 0.28%。</p>
</div><h2>Hedge Funds Weigh In On UnitedHealth Group</h2>
<div class="lb-trans"><h2>对联合健康集团的对冲基金看法</h2>
</div><p>A number of institutional investors have recently made changes to their positions in the stock. GAMMA Investing LLC lifted its position in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter. Nuveen LLC acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $3,846,764,000. Vanguard Group Inc. increased its stake in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP raised its stake in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after acquiring an additional 2,301,010 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些机构投资者最近对该股票的持仓进行了调整。GAMMA Investing LLC 在第一季度将其在联合健康集团的持仓增加了 56,142.1%。GAMMA Investing LLC 目前拥有 8,295,153 股该医疗保健集团的股票，价值为 43,445,860,000 美元，此前在上个季度购买了 8,280,404 股。Nuveen LLC 在第一季度获得了联合健康集团的新股份，价值约为 3,846,764,000 美元。先锋集团在第一季度将其在联合健康集团的股份增加了 6.6%。先锋集团目前拥有 90,729,585 股该医疗保健集团的股票，价值为 47,519,620,000 美元，此前在该期间购买了 5,583,343 股。威灵顿管理集团在第一季度将其在联合健康集团的股份增加了 10.6%。威灵顿管理集团目前拥有 25,847,940 股该医疗保健集团的股票，价值为 13,537,859,000 美元，此前在上个季度购买了 2,486,839 股。最后，瑞银资产管理美洲有限公司的一个独立业务单位在第四季度将其在联合健康集团的股份增加了 36.6%。瑞银资产管理美洲有限公司的这个独立业务单位目前拥有 8,592,718 股该医疗保健集团的股票，价值为 4,346,712,000 美元，此前在上个季度购买了 2,301,010 股。87.86% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>About UnitedHealth Group</h2>
<div class="lb-trans"><h2>关于联合健康集团</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p>
<div class="lb-trans"><p>联合健康集团在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：UnitedHealthcare、Optum Health、Optum Insight 和 Optum Rx。UnitedHealthcare 部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务，以满足他们的需求；医疗补助计划、儿童健康保险和医疗保健项目；以及健康和牙科福利、医院和临床服务，以及为照顾经济困难、医疗服务不足和没有雇主资助医疗保险的州项目提供的医疗保健福利产品和服务。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than UnitedHealth Group</li>
<li>Transportation Stocks Investing</li>
<li>Higher Consumer Confidence Could Benefit These 3 Retail Stocks</li>
<li>Stock Splits, Do They Really Impact Investors?</li>
<li>2 Cybersecurity Giants Nearing Big Potential Breakouts</li>
<li>Why Are These Companies Considered Blue Chips?</li>
<li>Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比联合健康集团更好的股票</li>
<li>交通运输股票投资</li>
<li>消费者信心上升可能使这三只零售股票受益</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>两家网络安全巨头即将迎来重大潜在突破</li>
<li>为什么这些公司被认为是蓝筹股？</li>
<li>Spotify 第二季度收益暴跌：机会还是不祥信号？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=UNH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在联合健康集团吗？</h2>
</div><p>Before you consider UnitedHealth Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑联合健康集团之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前立即购买……而联合健康集团并不在名单上。</p>
</div><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然联合健康集团目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

罗伯特·W·贝尔德重申对联合健康集团（UNH）的 “表现不佳” 评级